Ashoka Buildcon Shares Jump 15% on ₹866 Crore NHAI Expressway Contract

NHAI Award Puts Ashoka Buildcon’s Expressway Execution in Focus

A major highway contract has lifted the stock, but delivery over the next 18 months will matter more than the initial market reaction.

Ashoka Buildcon has secured an ₹865.90 crore NHAI contract for balance work on an eight-lane section of the Vadodara-Mumbai Expressway in Gujarat. The project adds a defined execution commitment, with an 18-month completion schedule and a 10-year defect liability period. Shares surged intraday, although the stock remains sharply lower over the past year.

A sizeable addition to the expressway order book

The Letter of Acceptance from the National Highways Authority of India covers the 26.6-km Karvad-to-Jujuwa stretch of the Vadodara-Mumbai Expressway, from Km 128.0 to Km 154.6. Ashoka Buildcon will execute the work on an engineering, procurement and construction basis. The accepted contract value is ₹865.90 crore, excluding GST.

For an EPC contractor, an award of this size provides a specific project to deliver against rather than an open-ended business opportunity. The contract value indicates the scale of the assignment, but it does not by itself establish how much revenue or profit the company will ultimately recognise. That will depend on execution and the economics of completing the work, details not provided in the announcement.

The schedule and liability period sharpen the execution test

The project is scheduled for completion within 18 months. That timetable makes progress on the balance work an important measure to watch: winning the contract is the first step, while meeting the schedule will determine how effectively the award translates into delivered work. The project’s status as balance work also means the assignment is to complete an existing stretch, rather than construct an entirely new expressway section.

See also  Rupee Under Pressure as RBI Defends 95.45 vs Dollar Amid Oil Surge

The 10-year defect liability period extends the contractor’s responsibility beyond the scheduled construction phase. It is a relevant part of the contract terms for investors assessing the commitments attached to the award, though the available information does not quantify any related costs or potential claims.

A sharp bounce, against a weaker longer-term record

Ashoka Buildcon shares rose as much as 14.7% intraday to ₹117.30 on Wednesday, before trading 9.48% higher at ₹112.80 at 10:22 AM on the NSE. The Nifty 50 was up 1.2% at that time. The contrast suggests the contract announcement was a clear catalyst for the stock’s outperformance in that session.

The advance follows gains of 9.32% over the past week and 11.86% over the past month, ahead of the Nifty Total Market index’s respective increases of 4.71% and 8.72%. But the longer-term picture remains more challenging: Ashoka Buildcon is down 32.02% year to date and 42.11% over the past year. A one-day rally therefore should not be treated as evidence that the broader decline has reversed.

Globe Capital Market’s Vipin Kumar said the shares had bounced from a ₹90–95 support zone and pointed to ₹134–140 as a possible technical level, citing the one-year exponential moving average and a price-resistance zone. That is an analyst’s market view, not a company forecast or assurance that the stock will reach those levels.

Key Highlights

  • Ashoka Buildcon received an NHAI Letter of Acceptance for ₹865.90 crore, excluding GST.
  • The EPC contract covers 26.6 km of the Vadodara-Mumbai Expressway in Gujarat.
  • Completion is scheduled within 18 months, with a 10-year defect liability period.
  • The stock gained as much as 14.7% intraday, but remains down 42.11% over the past year.
  • The cited technical levels are an analyst view and should be distinguished from the project’s confirmed contract terms.
See also  Dr Reddy’s Shares Dip 2.36% to Rs 1,177.50

Investor Note: The NHAI award gives Ashoka Buildcon a defined project and delivery timetable, while the share-price response reflects investor interest in the contract. Investors may want to weigh that opportunity against the execution schedule, long defect liability period and the stock’s substantial declines over longer periods; the award alone does not establish future profitability or a sustained share-price recovery.

Spread the Word

Stay Ahead of the Market 📈

Subscribe to our weekly newsletter

Get your weekly market summary from FinBrooks Insights and smart financial lessons from FinBrooks Academy delivered straight to your inbox every weekend!

Leave a Reply

Your email address will not be published. Required fields are marked *